PATENT CLAIM ANALYSIS

Application Number: 15917492
Application Type: Utility
Filing Date: 2018-03
Publication Date: 2018-09
Patent Classification: ["424", "236100"]

Abstract:
A method for treating abnormalities of the first metatarsophalangeal joint of the foot of a mammal includes administering an amount of neuromuscular toxin effective to treat the abnormalities via intramuscular injection to the extensor hallucis brevis muscle of the affected foot of the mammal. Further effectiveness can be achieved by also administering the toxin to adductor hallucis and/or the flexor hallucis brevis (lateral head) muscles of the affected foot. One of the abnormalities to be treated is hallux abductovalgus, commonly referred to as a bunion.

Claim (Index 7):
The method of  claim 5 , wherein the selective injection is conducted on the transverse head.

Metadata:
- Claim Count in Document: 38.0
- Percentile: 90.0
- Lexical Diversity: 1.625
- Patent Class: 424.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['11056382', '11504198', '14791389', '12748404', '14540567']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.743326082026855
- 35 USC 102 Novelty (BERT): 0.5788977417349863
- Combined Prediction Score: 0.7268832479976681
- Mean Citation Score: 308.404234
- Max Citation Score: 591.5578
- Similarity Product: 356.56301734660866

Labels:
- Claim Label 101: 1
- Claim Label 102: 0
- Claim Label 103: 0
- Claim Label 112: 0
- Combined Label: 0
- Label 101 Adjusted: 1

Dataset: test